Skip to main content
. 2021 Dec 10;2021(1):718-725. doi: 10.1182/hematology.2021000224

Table 1.

Prerequisites for MRD testing as a basis for treatment decisions

Optimal material • Material from primary diagnosis (aspirate, biopsy)
• Sufficient material and blast content
• Selection of correct material (PB/BM)
Skilled laboratory • Experience (number of ALL cases)
• Participation in quality-control rounds
• International standards for methods
Reporting of results • Timely and reliable reporting
• Results for each time point should include
 ○ Level of MRD
 ○ Sensitivity in case of a negative result
 ○ Further specification in case of nonquantifiable MRD
Terminology for MRD response • MRD response is evaluated in patients with hematologic CR
• Clear definition of results similar to definition of hematologic CR6,7
MRD CR:
○ MRD-negative with a minimum sensitivity of 0.01%
MRD failure:
○ MRD-positive ≥0.01%
MRD intermediate:
○ All other types of results, eg,
○ MRD-positive below 0.01%
○ Nonquantifiable but detectable MRD below 0.01% (PNQ)
○ MRD-negative with insufficient sensitivity